MA24604A1 - Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant - Google Patents

Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant

Info

Publication number: MA24604A1
Authority: MA; Morocco
Prior art keywords: blocker; novel compositions; selective serotonin; reabsorption inhibitor; serotonin reabsorption
Prior art date: 1997-07-11

Application number

MA25165A

Other languages

English (en)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-11

Filing date

1998-07-10

Publication date

1999-04-01

1998-07-10 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-04-01 Publication of MA24604A1 publication Critical patent/MA24604A1/fr

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
239000003112 inhibitor Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000009103 reabsorption Effects 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

MA25165A 1997-07-11 1998-07-10 Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant MA24604A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9714675.7A GB9714675D0 (en)	1997-07-11	1997-07-11	Novel composition

Publications (1)

Publication Number	Publication Date
MA24604A1 true MA24604A1 (fr)	1999-04-01

Family

ID=10815744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25165A MA24604A1 (fr)	1997-07-11	1998-07-10	Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant

Country Status (26)

Country	Link
EP (1)	EP0996466A2 (fr)
JP (1)	JP2002508003A (fr)
KR (1)	KR20010021644A (fr)
CN (1)	CN1262627A (fr)
AP (1)	AP2000001728A0 (fr)
AR (1)	AR016128A1 (fr)
AU (1)	AU9340198A (fr)
BG (1)	BG104119A (fr)
BR (1)	BR9810996A (fr)
CA (1)	CA2295822A1 (fr)
CO (1)	CO4950552A1 (fr)
DZ (1)	DZ2556A1 (fr)
EA (1)	EA200000112A1 (fr)
GB (1)	GB9714675D0 (fr)
HU (1)	HUP0003074A3 (fr)
ID (1)	ID24191A (fr)
IL (1)	IL133869A0 (fr)
MA (1)	MA24604A1 (fr)
NO (1)	NO20000107L (fr)
OA (1)	OA11276A (fr)
PE (1)	PE99699A1 (fr)
PL (1)	PL338017A1 (fr)
SK (1)	SK72000A3 (fr)
TR (1)	TR200000074T2 (fr)
WO (1)	WO1999002142A2 (fr)
ZA (1)	ZA986138B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69942009D1 (de)	1998-10-15	2010-03-25	Imp Innovations Ltd	Verbindungen für die behandlung von gewichtsverlust
IL142896A0 (en)	1998-11-02	2002-04-21	Elan Corp Plc	Multiparticulate modified release composition
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
EP2295043A1 (fr)	1999-10-29	2011-03-16	Euro-Celtique S.A.	Formulations d'hydrocodone à liberation lente
GB0004003D0 (en) *	2000-02-22	2000-04-12	Knoll Ag	Therapeutic agents
AU2002227383B2 (en)	2000-10-30	2004-07-08	Euro-Celtique S.A.	Controlled release hydrocodone formulations
WO2006030306A2 (fr) *	2004-09-17	2006-03-23	Neurocure Ltd	Methodes et compositions pour le traitement du syndrome premenstruel (pms) et d'un trouble dysphorique premenstruel (pmdd)
CN100469356C (zh) *	2006-09-08	2009-03-18	山东益康药业有限公司	复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2732335C2 (de) *	1976-07-27	1983-01-20	Sandoz-Patent-GmbH, 7850 Lörrach	Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (fr) *	1994-06-16	1997-06-03	David Taiwai Wong	Potentialisation des effets de medicaments
EP0714663A3 (fr) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
PT759299E (pt) *	1995-08-16	2000-09-29	Lilly Co Eli	Potenciacao da resposta de serotonina
EP0792649A1 (fr) *	1996-02-29	1997-09-03	Eli Lilly And Company	Traitement de l'insomnie

1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
1998
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/fr not_active Withdrawn
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/fr not_active Ceased
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/fr not_active Abandoned
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Withdrawn
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/fr active
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown

Also Published As

Publication number	Publication date
OA11276A (en)	2003-07-31
HUP0003074A3 (en)	2001-12-28
EA200000112A1 (ru)	2000-10-30
BR9810996A (pt)	2000-08-08
AU9340198A (en)	1999-02-08
HUP0003074A2 (hu)	2001-01-29
CA2295822A1 (fr)	1999-01-21
ID24191A (id)	2000-07-13
TR200000074T2 (tr)	2000-05-22
CO4950552A1 (es)	2000-09-01
WO1999002142A2 (fr)	1999-01-21
PL338017A1 (en)	2000-09-25
WO1999002142A3 (fr)	1999-04-15
ZA986138B (en)	2000-01-10
CN1262627A (zh)	2000-08-09
JP2002508003A (ja)	2002-03-12
BG104119A (en)	2000-12-29
EP0996466A2 (fr)	2000-05-03
NO20000107D0 (no)	2000-01-10
SK72000A3 (en)	2000-12-11
NO20000107L (no)	2000-01-10
KR20010021644A (ko)	2001-03-15
GB9714675D0 (en)	1997-09-17
DZ2556A1 (fr)	2003-02-15
AP2000001728A0 (en)	2000-03-31
PE99699A1 (es)	1999-12-21
IL133869A0 (en)	2001-04-30
AR016128A1 (es)	2001-06-20

Publication	Publication Date	Title
CY2012029I2 (el)	2015-08-05	Nεα μορφη της 5-ομεπραζολης
FI963398L (fi)	1996-08-30	Kielenalainen tai poskensisäinen farmaseuttinen koostumus
EE200000365A (et)	2001-10-15	Bispidiini uued arütmiavastased ühendid
EP0984692A4 (fr)	2001-02-21	Nouveaux inhibiteurs d'angiogenese
PT1014987E (pt)	2004-06-30	Composicoes orais de levosimendano
DE69310957D1 (de)	1997-07-03	Organosiliconzusammensetzungen
MA24626A1 (fr)	1999-04-01	Compositions parenterales d'alatrofloxacine
NO20002279D0 (no)	2000-04-28	Sammensetninger av lipidsenkende midler
EP1023068A4 (fr)	2001-05-16	ANTAGONISTES DES ADRENORECEPTEURS ALPHA 1a
DZ2556A1 (fr)	2003-02-15	Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant.
EP1014973A4 (fr)	2000-09-20	ANTAGONISTES DES ADRENORECEPTEURS ALPHA 1a
FI943921L (fi)	1996-02-27	Vapaan trypsinogeeni-2:n määritys
EP0824453A4 (fr)	1998-08-05	Nouvelles utilisations d'heptafluoropropane
FI991343A7 (fi)	1999-06-11	Dihydropolyprenolien öljykoostumus
KR960031416U (ko)	1996-10-22	투포원연사기의 스핀들
UA1629S (uk)	1997-10-31	Набір фестонів "веснянка-5"
UA1498S (uk)	1997-06-30	Набір етикеток "сумська горобинова"
UA1497S (uk)	1997-06-30	Набір етекеток "ярославна"
UA1499S (uk)	1997-06-30	Набір етикеток "гусарська"
UA1496S (uk)	1997-06-30	Набір етикеток "зубровка"
UA1904S (uk)	1998-04-30	Набір етикеток "недригайлівська"
UA1693S (uk)	1997-12-25	Набір етикеток "суми"
UA2269S (uk)	1998-10-30	Комплект етикеток "миротворча"
UA2189S (uk)	1998-08-31	Комплект етикеток "стольник"
UA2100S (uk)	1998-06-30	Комплект етикеток "хортиця"